THE MAN BEHIND SUN PHARMA: DILIP SANGHVI
•
4 likes•491 views
Dilip Shanghvi (born 1 October 1955) is an Indian businessman and one of the country's richest people. He founded Sun Pharmaceuticals with a partner, Pradeep Ghosh.[3] The Government of India awarded him the civilian honour of the Padma Shri in 2016.[4] India Today magazine ranked him #8th in India's 50 Most powerful people of 2017 list.[
Report
Share
Report
Share
![1
THE MAN BEHIND SUN PHARMA: DILIP SANGHVI
VARUN KESAVAN, RESEARCH SCHOLAR, E – MAIL ID –
varunkesavan@yahoo.com
Dilip Shanghvi (born 1 October 1955) is an Indian businessman and one of the
country's richest people. He founded Sun Pharmaceuticals with a partner, Pradeep
Ghosh.[3] The Government of India awarded him the civilian honour of the Padma
Shri in 2016.[4] India Today magazine ranked him #8th in India's 50 Most powerful
people of 2017 list.[](https://image.slidesharecdn.com/dilipsanghvi-171118072132/85/THE-MAN-BEHIND-SUN-PHARMA-DILIP-SANGHVI-1-320.jpg)
![2
EARLY LIFE AND EDUCATION
Dilip was born in small town of Amreli in Gujarat to Shantilal Sanghvi and Kumud
Sanghvi.[1][6] Shanghvi earned a Bachelor of Commerce degree from the University
of Calcutta.[7] He is an alumnus of J. J. Ajmera High School and Bhawanipur
Education Society College, from where he did his schooling and graduation,
respectively.[8] He is married to Vibha Sanghvi.[6][9] The couple have a son, Aalok and
daughter Vidhi from their marriage. Both of whom are currently working in Sun
Pharmaceuticals.
CAREER
He started by helping his father in his wholesale generic drugs business in Kolkata.[1]
It
was during his work as a drugs distributor at Kolkata, he thought of manufacturing his
own drugs instead of selling others' products.[1]
Dilip Shanghvi started Sun
Pharmaceutical Industries with capital of ₹10,000 in 1982 at Vapi, with one psychiatry
drug and a partner, Pradeep Ghosh.[1][3]
In 1997, Sun acquired Caraco Pharma, a loss-
making American company, with the aim of expanding Sun's reach in the United States.
Sun also acquired Israel's Taro Pharma in 2007.[11]
Shanghvi stepped down as
Chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva
Pharmaceuticals, as his successor;[3]
Shangvi became Managing Director.[12]
In April
2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed
that Sun would acquire all outstanding shares of Ranbaxy for $3.2B in Sun stock and
that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and
made Sun the largest drug company in India and the fifth largest in the world, and made
Daiichi the second largest shareholder in Sun.[13][14][15]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Dileep Shanghvi
Dileep Shanghvi is an Indian billionaire businessman who founded Sun Pharmaceutical Industries in 1982. Over the decades, he grew the company through strategic acquisitions to become the largest pharmaceutical company in India and among the top five largest generic drug makers globally. Some of his major acquisitions include Ranbaxy Laboratories for $4 billion in 2014, making Sun Pharma the largest Indian pharma company in the US. Shanghvi was awarded the Padma Shri in 2016 for his contributions to the pharmaceutical industry in India.
Dilip Shanghvi
Dilip Shanghvi founded Sun Pharmaceuticals in 1983 with a loan of Rs. 10,000 from his father. He started the company in Kolkata and later moved headquarters to Mumbai. Sun Pharma has grown to become the fifth largest drug maker in India through strategic acquisitions both in India and abroad. Shanghvi successfully turned around loss-making companies after acquiring them. Sun Pharma focuses on specialty and niche drugs, and over 70% of its sales come from India, though it also has operations in the US.
Presentation1.pptxdilip shanghvi
Dilip Shanghvi is the founder and managing director of Sun Pharmaceuticals, which he started in 1982 with Rs. 10,000 capital. Under his leadership, Sun Pharmaceuticals has grown to become India's largest drugmaker and most valuable pharmaceutical company. Shanghvi launched his career helping his father's wholesale drugs business and realized he could manufacture his own drugs. Through strategic acquisitions over the decades, Sun Pharmaceuticals now has a global presence and Shanghvi has a net worth of over $18 billion, making him one of Asia's richest self-made billionaires.
top 10 Pharma industry 2020
This document summarizes the top 10 pharmaceutical companies in India by market capitalization in June 2020. It provides brief histories and descriptions of each company, including their founding dates and locations, major products and therapeutic areas, and growth over time to become leaders in the Indian pharmaceutical market. The companies discussed are Sun Pharmaceuticals, Dr. Reddy's Laboratories, Divi's Laboratories, Cipla, Aurobindo Pharma, Torrent Pharmaceuticals, Lupin Ltd, Zydus Cadila Healthcare, Abbott India, and Alkem Laboratories.
Sun pharma Industries limited at a Glance
Sun pharma Key facts/ Numbers / details/ history / market/ business/ Analysis of annual report/ Key managerial person/ Indian pharma/ Ranbaxy laboratories
Top 3 Pharma companies in INDIA
Sun Pharmaceuticals was established in 1983 by Dilip Shanghvi and operates in over 150 countries. In 2014 it acquired Ranbaxy Laboratories and became the largest pharmaceutical company in India and fifth largest worldwide. Lupin is the second largest Indian pharma company producing over 5,500 products and has a market capitalization of Rs. 76,613 crore. Dr. Reddy's Laboratories is the third largest founded in 1984 producing over 200 products globally across 20 countries with a market capitalization of Rs. 50,102 crore.
Top 10 pharma companies in Kerala | Pharmaadda
Choose the Best Pharmaceutical company in Kerela from the above list. These companies provide you all the required service as per your needs. For more information visit http://www.pharmaadda.in/top-10-pharma-companies-in-kerala
Top 10 Pharma Companies in Vadodara | Pharmaadda
Listed companies are the Top Pharma companies in Vadodara, Gujrat which supplies their medicines and drugs all over India. Visit the http://www.pharmaadda.in/top-10-pharma-companies-in-vadodara for details.
Recommended
Dileep Shanghvi
Dileep Shanghvi is an Indian billionaire businessman who founded Sun Pharmaceutical Industries in 1982. Over the decades, he grew the company through strategic acquisitions to become the largest pharmaceutical company in India and among the top five largest generic drug makers globally. Some of his major acquisitions include Ranbaxy Laboratories for $4 billion in 2014, making Sun Pharma the largest Indian pharma company in the US. Shanghvi was awarded the Padma Shri in 2016 for his contributions to the pharmaceutical industry in India.
Dilip Shanghvi
Dilip Shanghvi founded Sun Pharmaceuticals in 1983 with a loan of Rs. 10,000 from his father. He started the company in Kolkata and later moved headquarters to Mumbai. Sun Pharma has grown to become the fifth largest drug maker in India through strategic acquisitions both in India and abroad. Shanghvi successfully turned around loss-making companies after acquiring them. Sun Pharma focuses on specialty and niche drugs, and over 70% of its sales come from India, though it also has operations in the US.
Presentation1.pptxdilip shanghvi
Dilip Shanghvi is the founder and managing director of Sun Pharmaceuticals, which he started in 1982 with Rs. 10,000 capital. Under his leadership, Sun Pharmaceuticals has grown to become India's largest drugmaker and most valuable pharmaceutical company. Shanghvi launched his career helping his father's wholesale drugs business and realized he could manufacture his own drugs. Through strategic acquisitions over the decades, Sun Pharmaceuticals now has a global presence and Shanghvi has a net worth of over $18 billion, making him one of Asia's richest self-made billionaires.
top 10 Pharma industry 2020
This document summarizes the top 10 pharmaceutical companies in India by market capitalization in June 2020. It provides brief histories and descriptions of each company, including their founding dates and locations, major products and therapeutic areas, and growth over time to become leaders in the Indian pharmaceutical market. The companies discussed are Sun Pharmaceuticals, Dr. Reddy's Laboratories, Divi's Laboratories, Cipla, Aurobindo Pharma, Torrent Pharmaceuticals, Lupin Ltd, Zydus Cadila Healthcare, Abbott India, and Alkem Laboratories.
Sun pharma Industries limited at a Glance
Sun pharma Key facts/ Numbers / details/ history / market/ business/ Analysis of annual report/ Key managerial person/ Indian pharma/ Ranbaxy laboratories
Top 3 Pharma companies in INDIA
Sun Pharmaceuticals was established in 1983 by Dilip Shanghvi and operates in over 150 countries. In 2014 it acquired Ranbaxy Laboratories and became the largest pharmaceutical company in India and fifth largest worldwide. Lupin is the second largest Indian pharma company producing over 5,500 products and has a market capitalization of Rs. 76,613 crore. Dr. Reddy's Laboratories is the third largest founded in 1984 producing over 200 products globally across 20 countries with a market capitalization of Rs. 50,102 crore.
Top 10 pharma companies in Kerala | Pharmaadda
Choose the Best Pharmaceutical company in Kerela from the above list. These companies provide you all the required service as per your needs. For more information visit http://www.pharmaadda.in/top-10-pharma-companies-in-kerala
Top 10 Pharma Companies in Vadodara | Pharmaadda
Listed companies are the Top Pharma companies in Vadodara, Gujrat which supplies their medicines and drugs all over India. Visit the http://www.pharmaadda.in/top-10-pharma-companies-in-vadodara for details.
Nakul lupin
This report is based on the summer training undertaken with lupin ltd anleshwar. It will be beneficial to the students who appear for training with lupin ankleshwar. The report also contains mini project on job rotation and transfer.
Top pharma capsule manufacturer in India
We are providing all the important information regarding Top Pharma Capsule Manufacturer in India. Our India is one of the best Pharmaceutical Capsules Manufacturer.
Lupin Summer training
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
STRUCTURING QUALITY MEDICINES AND HEALTHCARE
Psychotropics India Ltd. is a pharmaceutical company founded in 1987 by Navdeep Chawla. It has since expanded from psychiatric drugs into several other therapeutic areas and produces over 400 healthcare products. The company has 4 manufacturing plants, exports products to Africa, the Middle East, and Southeast Asia, and has a turnover of Rs. 200 crores. Navdeep's son Siddharth now looks after manufacturing and exports, while his daughter Geetika manages the animal health division. The company aims to continue providing affordable, high quality medicines.
SLPL Group Pharma Profile
Praful Wahadude founded the SLPL Group of companies in 2000. SLPL Group engages in pharmaceuticals, construction, and tourism businesses. Specifically, SLPL is a pharmaceutical company that manufactures over 350 drug formulations, including active pharmaceutical ingredients and generics. It has a presence across Maharashtra, Madhya Pradesh, and Chhattisgarh, catering to over 21,000 physicians through hospitals, institutes, and nursing homes.
Dr reddy
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company founded by Anji Reddy. It began as an API supplier in India and exported to less regulated markets, using profits to gain approvals in markets like the US and Europe. Today it has over 15,000 employees across 17 countries and manufactures over 190 medications and 60 APIs. It focuses on generics and has expanded into areas like biotechnology and diagnostics through strategic collaborations.
Square
The document discusses the Square Group, a conglomerate founded in 1958 by Samson H. Chowdhury in Bangladesh. It has grown to 14 companies with a group turnover of about $616 million USD. Samson H. Chowdhury started his career in 1952 with a small pharmacy and established Square Pharmaceuticals Ltd. in 1958. Under his leadership, Square Group became a market leader in Bangladesh and pioneered pharmaceutical exports. It contributes significantly to the Bangladeshi economy through employment, taxes, products, and donations. The group also has a strong commitment to corporate social responsibility through various education, health, and community initiatives.
Top 10 PCD Companies in Thiruvananthapuram, Kerala
Thiruvananthapuram is capital of Kerala with highest population in the sate. Pharma sector is also doing great business here. If you are looking for a right opportunity then go with these Top 10 PCD Companies in Thiruvananthapuram Kerala.
List of pharma companies in Indore | Pharmaadda
Mentioned in above list are the Top Pharma Companies in Indore. Invest in these companies to enhance your business growth. For More details visit http://www.pharmaadda.in/list-of-pharma-companies-in-indore
Top cardiac diabetic franchise companies in india ppt
Listed in my blog, is the Top Cardiac Diabetic Franchise Companies in India. Invest in these Cardiac Diabetic PCD firms for quality diabetic product range. Visit http://www.pharmaadda.in/top-cardiac-diabetic-franchise-companies-in-india
Novartis
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
Principle and practices of it enabled management
The board of directors of Sun Pharma consists of 9 members, including the founder and Managing Director Dilip Shanghvi. The other directors include the Chairman Israel Makov, a former CEO of Teva Pharmaceutical Industries. Executive directors Sudhir V. Valia and Sailesh T. Desai have over 30 years of experience in finance/taxation and the pharmaceutical industry respectively. The remaining 6 directors including Keki Mistry, Ashwin Dani, and Rekha Sethi serve as non-executive independent directors. Dilip Shanghvi holds the largest ownership stake in Sun Pharma at 11.16% of total shares.
Presentation on CIPLA
HISTORY, About the CIPLA , How The pharmaceutical works
CIPLA Products ,SWOT ANALYSIS ,Synergy Opportunities
Top oncology pharma companies in india
In this topic we discuss about the Top Oncology companies in India with their full information regarding address, Phone no.for the convenience of the people.
Top 100 pharma companies in india converted
Let's get into a brief look at the Top 100 Pharmaceutical Companies In India along with the contact details of top decision-makers.
Top Pharma Capsule Manufacturer in India
We are providing all the important information regarding Top Pharma Capsule Manufacturer in India. Our India is one of the best Pharmaceutical Capsules Manufacturer. We have wide range of drug medicines for various therapeutic segments. Capsules have great demand when it comes in the medicines.
Timeline of Cadila Pharmaceuticals
Cadila Pharmaceuticals is an Indian multinational pharmaceutical group based in Ahmedabad, Gujarat, India. With more than 6 decades of experience, the company's integrated operations focus on manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products and pharmaceutical Machinery.
News
Traser, a Swiss watch brand known for permanent illumination technology, will debut in India next year through a partnership with watch retailer Ethos. Nestle increased its stake in its Indian arm Nestle India to 62.76% and may consider delisting from Indian exchanges in the long term. Cadbury will start local manufacturing of Tang orange drink in India at Kraft's Hyderabad plant. Nissan will unveil the diesel variant of its Micra hatchback in India, making it the first country to have this version. The government banned the anti-obesity drug Sibutramine and its combination drugs due to side effects.
Itc ppt
This document provides an overview of ITC Limited, an Indian conglomerate company. It discusses ITC's business portfolio which includes cigarettes, FMCG goods, hotels, paperboards, and IT. The document also summarizes ITC's vision, products and brands, competition in the atta market from brands like Shakti Bhog and Pillsbury, and provides a PESTEL, SWOT and financial analysis of ITC.
Best pharma company in india
Ind-Swift is a leading pharmaceutical company based in Chandigarh, India that was founded in 1986. It focuses on innovative pharmaceutical products and has been ranked 35th largest in the Indian pharmaceutical industry and second largest in North India. The company is organized into several divisions including Mega Swift, Gyno Swift, Generic, and Institutional divisions.
Newsletter dated 02nd june, 2016
Dilip Shanghvi is an Indian businessman who is the founder and managing director of Sun Pharmaceuticals. He started the company in 1982 with just Rs. 10,000 and has built it into India's largest drugmaker and most valuable pharmaceutical company with a market cap over Rs. 1.2 lakh crore. Shanghvi acquired multiple companies over the years to expand Sun Pharma's global reach, including acquiring Ranbaxy Laboratories for $4 billion in 2014. As of 2015, he became the richest person in India, overtaking Mukesh Ambani, with a net worth of over $17 billion according to Bloomberg.
Newsletter dated 06th September, 2016
The document summarizes information about Dilip Shanghvi, the founder and managing director of Sun Pharmaceuticals. It states that he started Sun Pharma in 1982 with just Rs. 10,000 capital and it has now grown to a market cap of over Rs. 1.2 lakh crore. It also mentions that he created history by acquiring Ranbaxy Labs for $4 billion, making Sun Pharma the fifth largest pharma company in the world. The summary provides background on Shanghvi, including that he was born in Gujarat, earned a commerce degree, and started his career helping his father's drug business, which inspired him to start his own drug company.
More Related Content
What's hot
Nakul lupin
This report is based on the summer training undertaken with lupin ltd anleshwar. It will be beneficial to the students who appear for training with lupin ankleshwar. The report also contains mini project on job rotation and transfer.
Top pharma capsule manufacturer in India
We are providing all the important information regarding Top Pharma Capsule Manufacturer in India. Our India is one of the best Pharmaceutical Capsules Manufacturer.
Lupin Summer training
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
STRUCTURING QUALITY MEDICINES AND HEALTHCARE
Psychotropics India Ltd. is a pharmaceutical company founded in 1987 by Navdeep Chawla. It has since expanded from psychiatric drugs into several other therapeutic areas and produces over 400 healthcare products. The company has 4 manufacturing plants, exports products to Africa, the Middle East, and Southeast Asia, and has a turnover of Rs. 200 crores. Navdeep's son Siddharth now looks after manufacturing and exports, while his daughter Geetika manages the animal health division. The company aims to continue providing affordable, high quality medicines.
SLPL Group Pharma Profile
Praful Wahadude founded the SLPL Group of companies in 2000. SLPL Group engages in pharmaceuticals, construction, and tourism businesses. Specifically, SLPL is a pharmaceutical company that manufactures over 350 drug formulations, including active pharmaceutical ingredients and generics. It has a presence across Maharashtra, Madhya Pradesh, and Chhattisgarh, catering to over 21,000 physicians through hospitals, institutes, and nursing homes.
Dr reddy
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company founded by Anji Reddy. It began as an API supplier in India and exported to less regulated markets, using profits to gain approvals in markets like the US and Europe. Today it has over 15,000 employees across 17 countries and manufactures over 190 medications and 60 APIs. It focuses on generics and has expanded into areas like biotechnology and diagnostics through strategic collaborations.
Square
The document discusses the Square Group, a conglomerate founded in 1958 by Samson H. Chowdhury in Bangladesh. It has grown to 14 companies with a group turnover of about $616 million USD. Samson H. Chowdhury started his career in 1952 with a small pharmacy and established Square Pharmaceuticals Ltd. in 1958. Under his leadership, Square Group became a market leader in Bangladesh and pioneered pharmaceutical exports. It contributes significantly to the Bangladeshi economy through employment, taxes, products, and donations. The group also has a strong commitment to corporate social responsibility through various education, health, and community initiatives.
Top 10 PCD Companies in Thiruvananthapuram, Kerala
Thiruvananthapuram is capital of Kerala with highest population in the sate. Pharma sector is also doing great business here. If you are looking for a right opportunity then go with these Top 10 PCD Companies in Thiruvananthapuram Kerala.
List of pharma companies in Indore | Pharmaadda
Mentioned in above list are the Top Pharma Companies in Indore. Invest in these companies to enhance your business growth. For More details visit http://www.pharmaadda.in/list-of-pharma-companies-in-indore
Top cardiac diabetic franchise companies in india ppt
Listed in my blog, is the Top Cardiac Diabetic Franchise Companies in India. Invest in these Cardiac Diabetic PCD firms for quality diabetic product range. Visit http://www.pharmaadda.in/top-cardiac-diabetic-franchise-companies-in-india
Novartis
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
Principle and practices of it enabled management
The board of directors of Sun Pharma consists of 9 members, including the founder and Managing Director Dilip Shanghvi. The other directors include the Chairman Israel Makov, a former CEO of Teva Pharmaceutical Industries. Executive directors Sudhir V. Valia and Sailesh T. Desai have over 30 years of experience in finance/taxation and the pharmaceutical industry respectively. The remaining 6 directors including Keki Mistry, Ashwin Dani, and Rekha Sethi serve as non-executive independent directors. Dilip Shanghvi holds the largest ownership stake in Sun Pharma at 11.16% of total shares.
Presentation on CIPLA
HISTORY, About the CIPLA , How The pharmaceutical works
CIPLA Products ,SWOT ANALYSIS ,Synergy Opportunities
Top oncology pharma companies in india
In this topic we discuss about the Top Oncology companies in India with their full information regarding address, Phone no.for the convenience of the people.
Top 100 pharma companies in india converted
Let's get into a brief look at the Top 100 Pharmaceutical Companies In India along with the contact details of top decision-makers.
Top Pharma Capsule Manufacturer in India
We are providing all the important information regarding Top Pharma Capsule Manufacturer in India. Our India is one of the best Pharmaceutical Capsules Manufacturer. We have wide range of drug medicines for various therapeutic segments. Capsules have great demand when it comes in the medicines.
Timeline of Cadila Pharmaceuticals
Cadila Pharmaceuticals is an Indian multinational pharmaceutical group based in Ahmedabad, Gujarat, India. With more than 6 decades of experience, the company's integrated operations focus on manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products and pharmaceutical Machinery.
News
Traser, a Swiss watch brand known for permanent illumination technology, will debut in India next year through a partnership with watch retailer Ethos. Nestle increased its stake in its Indian arm Nestle India to 62.76% and may consider delisting from Indian exchanges in the long term. Cadbury will start local manufacturing of Tang orange drink in India at Kraft's Hyderabad plant. Nissan will unveil the diesel variant of its Micra hatchback in India, making it the first country to have this version. The government banned the anti-obesity drug Sibutramine and its combination drugs due to side effects.
Itc ppt
This document provides an overview of ITC Limited, an Indian conglomerate company. It discusses ITC's business portfolio which includes cigarettes, FMCG goods, hotels, paperboards, and IT. The document also summarizes ITC's vision, products and brands, competition in the atta market from brands like Shakti Bhog and Pillsbury, and provides a PESTEL, SWOT and financial analysis of ITC.
Best pharma company in india
Ind-Swift is a leading pharmaceutical company based in Chandigarh, India that was founded in 1986. It focuses on innovative pharmaceutical products and has been ranked 35th largest in the Indian pharmaceutical industry and second largest in North India. The company is organized into several divisions including Mega Swift, Gyno Swift, Generic, and Institutional divisions.
What's hot (20)
Top 10 PCD Companies in Thiruvananthapuram, Kerala
Top 10 PCD Companies in Thiruvananthapuram, Kerala
Top cardiac diabetic franchise companies in india ppt
Top cardiac diabetic franchise companies in india ppt
Similar to THE MAN BEHIND SUN PHARMA: DILIP SANGHVI
Newsletter dated 02nd june, 2016
Dilip Shanghvi is an Indian businessman who is the founder and managing director of Sun Pharmaceuticals. He started the company in 1982 with just Rs. 10,000 and has built it into India's largest drugmaker and most valuable pharmaceutical company with a market cap over Rs. 1.2 lakh crore. Shanghvi acquired multiple companies over the years to expand Sun Pharma's global reach, including acquiring Ranbaxy Laboratories for $4 billion in 2014. As of 2015, he became the richest person in India, overtaking Mukesh Ambani, with a net worth of over $17 billion according to Bloomberg.
Newsletter dated 06th September, 2016
The document summarizes information about Dilip Shanghvi, the founder and managing director of Sun Pharmaceuticals. It states that he started Sun Pharma in 1982 with just Rs. 10,000 capital and it has now grown to a market cap of over Rs. 1.2 lakh crore. It also mentions that he created history by acquiring Ranbaxy Labs for $4 billion, making Sun Pharma the fifth largest pharma company in the world. The summary provides background on Shanghvi, including that he was born in Gujarat, earned a commerce degree, and started his career helping his father's drug business, which inspired him to start his own drug company.
Newsletter dated 30th January, 2017
The document provides information about Dilip Shanghvi, the founder and managing director of Sun Pharmaceuticals. It details that he started Sun Pharma in 1982 with just Rs. 10,000 capital and it has now grown to a market cap of over Rs. 1.20 lakh crore. It also mentions that he is currently the richest person in India, having overtaken Mukesh Ambani, with a net worth of $17.2 billion according to Bloomberg. The document provides background on his education and early career in business before founding Sun Pharma to become one of India's most successful pharmaceutical entrepreneurs.
DiLIp Shanghvi(1).pptx
Dilip Shanghvi started Sun Pharmaceuticals in 1983 with just Rs. 10,000 borrowed from his father. He began his career helping his father's small pharmaceutical wholesale business in Kolkata. In Sun Pharmaceutical's first year, they did Rs. 7 lakhs in business. By the 1990s, Sun Pharma had begun making its presence felt in the industry. Shanghvi reinvested profits to set up an in-house research center. Today, Sun Pharmaceutical is the largest pharmaceutical company in India and fourth largest in the world, with Shanghvi having an estimated wealth of $12 billion in 2022.
Newsletter dated 12th November, 2015
Kallam Anji Reddy was an Indian industrialist and entrepreneur who founded Dr. Reddy's Laboratories in 1984. He transformed India's pharmaceutical industry from import-dependent to self-reliant and export-oriented. Reddy received many awards for his entrepreneurship and innovation. He was also a philanthropist who established the Dr. Reddy's Foundation for social development. Reddy passed away in 2013 at the age of 72, having made significant contributions to making medicines more affordable and accessible in India.
28435822 subhash-chandra-goyal
Subhash Chandra is an Indian media tycoon and founder of Zee TV, India's first private satellite television channel. He launched Zee TV in 1992, breaking the monopoly of state-run Doordarshan and pioneering satellite television in India. Since then he has expanded his media empire to include additional TV channels, cable distribution, movies, and other businesses. He has transformed from a rice trader into a billionaire media baron through his pioneering vision and successful expansion of satellite television in India.
Hindustan Unilever Limited
Hindustan Unilever Limited (HUL) is India's largest Fast Moving Consumer Goods Company. The document provides a detailed history of HUL from its inception in 1933 to 2010, including mergers, acquisitions, and expansion of its product portfolio and distribution network. It discusses HUL's presence across 20 categories, 700 million consumers in India, 39 factories, and distribution reaching over 1 million retail outlets and 6.3 million outlets. The document also notes HUL's recognition as the most respected company in India for 25 years and as one of the world's most reputed companies.
Ranbaxy pvt
This presentation contain the technical analysis of Ranbaxy pvt. ltd. and its performance in the market.
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
This document highlights 10 of the best Indian women entrepreneurs of 2016. It provides details about each entrepreneur, including their background, education, and achievements. Some of the entrepreneurs featured include Indu Jain (chairman of Bennett Coleman & Co), Kiran Mazumdar-Shaw (founder of Biocon), Indra Nooyi (CEO of PepsiCo), and Vandana Luthra (founder of VLCC). The entrepreneurs come from a variety of industries and have all made significant contributions to business and society in India.
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
This document highlights 10 of the best Indian women entrepreneurs of 2016. It provides details about each entrepreneur, including their background, education, and achievements. Some of the entrepreneurs featured include Indu Jain (chairman of Bennett Coleman & Co), Kiran Mazumdar-Shaw (founder of Biocon), Indra Nooyi (CEO of PepsiCo), and Vandana Luthra (founder of VLCC). The entrepreneurs come from a variety of industries and have all made significant contributions to business and society in India.
Principle and practices of it enabled management
Sun Pharma is a public pharmaceutical company founded in 1981 and headquartered in Mumbai, India. It has total assets of ₹15,500 crore and employs 52,700 people. The board of directors includes Dilip Shanghvi as the Managing Director and founder, as well as other executive and non-executive independent directors with experience in pharmaceuticals, finance, and management. Dilip Shanghvi holds the largest percentage of company shares at 11.16%.
Sun pharma acquires ranbaxy
Sun Pharmaceuticals acquired Ranbaxy in a $4 billion all-share deal in 2014. This created the fifth largest specialty generics company in the world. The merger strengthened Sun Pharma's global footprint, distribution network, and portfolio in key therapeutic areas. It gained access to Ranbaxy's brands and markets in regions like the US, Europe, Brazil, Russia, and China. However, Ranbaxy had been struggling financially prior to the acquisition due to regulatory and legal issues.
Sunpharma.pptx
Sun Pharmaceutical Industries Limited is the largest pharmaceutical company in India and the fourth largest generic pharmaceutical company worldwide. It was founded in 1983 by Dilip Shanghvi in Vapi, Gujarat, and has grown to sell over 2000 products in over 100 countries. Sun Pharma earns over 72% of its sales from international markets like the US, which is its single largest market. The company has over 40 manufacturing plants globally and employs over 41,000 people.
Chartered accountant in delhi (top 10 CA in delhi)
chartered accountant are professional accountants who manages auditing ,and taxes.
https://localdelhiguide.com/chartered-accountant-in-de
chartered accountant in delhi. (top 10 CA in delhi)
Chartered Accountants are experts in preparing, examining, and interpreting financial statements. They ensure that financial reports accurately reflect the financial condition and performance of an organization according to relevant accounting standards.
https://localdelhiguide.com/chartered-accountant-in-delhi/
Similar to THE MAN BEHIND SUN PHARMA: DILIP SANGHVI (15)
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
10 BEST INDIAN WOMEN ENTREPRENEURS OF THE YEAR 2016
Chartered accountant in delhi (top 10 CA in delhi)
Chartered accountant in delhi (top 10 CA in delhi)
chartered accountant in delhi. (top 10 CA in delhi)
chartered accountant in delhi. (top 10 CA in delhi)
More from VARUN KESAVAN
THE GROWTH ANALYSIS OF UNIFIED PAYMENTS INTERFACE (UPI) IN INDIA.docx
Interoperability among “payment systems in India has facilitated unparalleled ease of transactions while robust customer protection measures have made India’s retail payment system one of the safest in the world.
Unified Payments Interface (UPI) is a mobile-based, 365x24x7 ‘fast payment’ system launched in August 2016 which allows users to send and receive money instantly using a Virtual Payment Address (VPA) set by the user itself. The unique feature of VPA-based transaction is that it obviates the need for sharing account or bank details to the remitter. It supports person-to-person (P2P) and person-to-merchant (P2M) payments which can be used over a smart phone (app-based) or a feature phone (USSD8-based), and at merchant location/website. It facilitates immediate money transfer through both ‘pull’ and ‘push’ payments.
Non-financial transactions, such as balance enquiry, can also be carried out using UPI. It powers multiple bank accounts into a single mobile application of any participating bank/non-bank Third Party Application Provider (TPAP). Funds can also be transferred through UPI using account number with and IFSC (Indian Financial System Code) of the bank branch. The UPI 2.0 was launched in August 2018, which enabled users to link their Overdraft accounts to UPI VPA. Users are also able to pre-authorise transactions by issuing a mandate for specific merchant for a one-time payment. There’s also an added feature of AutoPay facility for recurring payments.
The framework of UPI comprises NPCI as switching and settlement service provider and banks as Payment System Providers (PSPs) – as issuer banks and beneficiary banks. Additionally, it can also have Third Party Application Providers (TPAP) such as Google Pay. Transactions are carried out through mobile devices with two-factor authentication using device binding and UPI PIN as security. Currently, the per transaction limit is INR 0.2 million.
UPI has attracted participation from a number of FinTech players. As against banks, it is the non-bank players who have made good use of the openness of UPI architecture, which allows any entity’s mobile application to be used for doing UPI transactions. Since its humble beginning in 2016, UPI has become one of the most popular payment products in India. Convenience of remembering and sharing a simple UPI VPA may have added to its popularity”.
On the whole we can observe there is a significant increase in the number of UPI transactions both in terms of volume and in terms of value. Similarly, from 17.86 million transactions in financial year 2016 – 2017 to 22,330.65 million transactions in the year 2021 – 2022 with the CAGR of 228%. Similarly with reference to value of transactions there is a increase in the value of transactions from Rs. 69.47 billion transactions in the year 2016 – 2017 to Rs. 41,036.54 billion transactions in the year 2021 – 2022 with the CAGR of 190%. UPI is going to be a catalyst in the retail payments sector in India.
WILL ROBOTS REDUCE OR INCREASE HUMAN EMPLOYMENT OPPORTUNITIES?
According to Binus Square Student Committee, Technology is disrupting the economy at many levels, and many worry about losing their jobs to automation. The truth is that this isn’t anything new—we’ve been through this already with the Industrial Revolution.
Back then, employees also thought there would be no room for humans at work. Machines were taking over, and their jobs were less valuable every day. But humans are still part of the equation; machines didn’t replace us—we use them to make our jobs more productive.
Today, we can expect a significant change in the way we handle our work, and we’ll probably have to learn new skills to future-proof our lives. The only difference between the previous industrial revolutions and today’s robotics revolution is the speed at which it is taking place.
According to a recent Oxford study, there will be 14 million robots in China’s workforce within the next 11 years. Artificial Intelligence, machine learning and robotics are accelerating the pace of automation in the workspace. However, there will always be jobs for humans. Now, let’s explore whether robots will reduce human employment or not.
GLOBAL TOURISM SECTOR TO SUFFER $1.2 TRILLION DUE TO COVID-19 PANDEMIC
Global tourism sector is set to lose at least $1.2 trillion due to the spread of coronavirus. Let's take a look at the impact.
The world's tourism sector could lose at least $1.2 trillion or 1.5 per cent of the global gross domestic product (GDP), having been on a standstill for nearly four months due to the coronavirus pandemic. The loss could rise to $2.2 trillion or 2.8 per cent of the world's GDP if the break in international tourism lasts for eight months, in line with the expected decline in tourism as projected by the UN World Tourism Organisation.
In the most pessimistic scenario, a 12-month break in international tourism would incur an estimated losses of $3.3 trillion or 4.2 per cent of global GDP. In absolute terms, the world's largest trading economies, USA and China would face the largest declines in GDP, in the moderate scenario.
Negative employment and wage effects would be highest in countries reliant on tourism. The steepest drops are estimated in Thailand (-12 per cent), Jamaica (-11 per cent), and Croatia (-9 per cent).
In the long run, the World Travel & Tourism Council anticipates that the international tourism sector will likely return to pre-pandemic levels within a 19-month period.
THE AFTERMATH EFFECTS OF CORONAVIRUS PANDEMIC ON THE INVESTMENTS IN REAL ESTA...
The COVID-19 pandemic has severely impacted real estate investments in India. Private equity investments in Indian real estate dropped by 93% in 2020 compared to the previous year. Residential real estate witnessed a 91% year-over-year decline in investments. Office investments also declined, dropping 81% in the first five months of 2020 versus the same period the previous year. The pandemic-induced lockdown slowed overall real estate investment activity and leasing in India.
THE JOURNEY BEHIND THE GLORY OF LARGEST ONLINE NEWS PLATFORM DAILYHUNT
We no longer have to wait for the newspaper to get the latest news, nor do we require to wait till we reach home and switch on the TV to know the breaking news. With mobile phones and fast and cheap internet services, news and information is now much easier to access. An entrepreneur, Virendra Gupta could foresee this situation even before it actually arrived, which led him to acquire Newshunt in 2012, which is currently known as Dailyhunt. Today Dailyhunt procures content from over 1000+ publishers and is getting much popularity as the content is available in 14 Indian regional languages. Lets have a look at the journey of this top Indian startup.
THE PATH BEHIND THE SHINING OF PAYMENTS APP MOBIKWIK
Using a Mobile Wallet has now turned out to be a habit of many. Easy hassle-free payment and no worries about hunting for change every time you purchase something probably is a major benefit of using a mobile wallet. While today many international players are providing mobile wallet services in India, MobiKwik is one of the pioneer Indian mobile wallet companies, that despite much competition has carved a niche for itself.
THE JOURNEY BEHIND THE GLORY OF ONLINE TRAVEL KING MAKEMY TRIP
India’s leading online travel company MakeMyTrip.com was founded in the year 2000 by Deep Kalra. Headquartered in Gurugram, Haryana, the company provides online travel services including flight tickets, domestic and international holiday packages, hotel reservations, rail and bus tickets.
As of March 31, 2018, the company has 14 company-owned travel stores in 14 cities, including one in their office in Gurugram, over 30 franchisee-owned travel stores which primarily sell packages in approximately 28 cities, and counters in four major airports in India under their brand. They also have offices in New York, Singapore, Kuala Lumpur, Phuket, Bangkok, and Dubai.
THE JOURNEY BEHIND THE SHINNING OF ONLINE INSURANCE AGGREGATOR POLICYBAZAAR
PolicyBazaar is India’s leading aggregator and marketplace of insurance products. Established in 2008, PolicyBazaar initially just compared the prices of insurance policies and provided insurance related information. Now, PolicyBazaar not only assists customers in buying insurance policies, but also provides assistance for cancellation/renewal of policies and even claim settlement.
PoicyBazaar is the marketplace for all insurance needs. It provides every thing from, life insurance, health insurance, motor insurance and other insurance like travel insurance and group insurance etc. The company offers more than 250 insurance plans and around 50 insurance brands on its platform. T
he platform is designed in a way that the visitors can easily compare the insurance plans and buy plans as per personal insurance needs.
The company is constantly adding new features and technology to make customer experience smoother. PolicyBazaar introduced 'my account' feature some times back. Through PolicyBazaar's 'My Account' feature, customers can easily download a policy, raise a ticket, ask for clarification and upgrade policies. The company introduced self inspection video feature for revival of lapsed motor insurance.
PolicyBazaar also adopted Amazon Polly and developed in-house AI chatbot - PBee to improve customer satisfaction.
In 2015, PolicyBazaar app was launched. The app is available for android and iOS platform. A customer can not only search, compare and buy insurance through the PolicyBazaar app, but there are also interesting features like hospital locator, garage locator, insurance premium calculator, instant renewal of insurance policies, claim assistance and more.
THE ROAD BEHIND THE GLORY OF GROCERY GIANT GROFERS
Grofers is an Indian online grocery delivery startup founded in 2013 by two IIT graduates. It operates in 28 Indian cities. Initially, the founders facilitated grocery deliveries from local stores and supermarkets for customers. They aimed to provide one-stop delivery for local needs by partnering with shops. Grofers works on a marketplace model, partnering with local grocery shops to fulfill online orders placed through its app, charging the shops commissions ranging from 8-15%. While Grofers has seen success, it also faced initial challenges including delayed service, product quality issues, and shutting down operations in some cities.
THE RELIANCE JIO WHICH TRANSFORMED THE FACE OF INDIAN TELECOM INDUSTRY
When Anil Ambani and Mukesh Ambani had a split in the year 2005 it was one of the biggest de-merger in the industry. The dream project of Mukesh Ambani that was Reliance Infocom became a part of Anil Ambani Group. Further Mukesh Ambani went on to acquire the company Infotel Broadband Services Limited which was the only successful bidder across India for the 4G network.
That is when Mukesh Ambani’s Reliance Limited started working in establishing a base for high-speed optical fiber 4G network which is much more capable than 4G. The company was named Reliance Jio Infocom Ltd popularly known as Jio today. Jio was the first network to provide 4G LTE services and VoLTE services.
Jio launched this service on 5th September 2016 for all the users and also launched its smartphone series with the name LYF. Reliance Jio Infocom Ltd (RJIL) focused on high-speed data instead of voice and SMS. On its launch, the company announced data plans with 1GB 4G data per day in the market where mostly all popular telecom providers offered 1GB data per month.
This was a game-changer by RJIL in the price-sensitive market of India as the prices before that revolved around Rs.250-300 for 1 GB 4G data which went down to Rs. 5 per GB during the initial days. With such amusing plans gradually Jio also offered free voice calling and free 100 SMS per day for all its Prime members.
THE NOTABLE CONTRIBUTIONS MADE BY CORPORATE GIANTS DURING THE OUTBREAK OF THI...
Tata Trusts and Tata Sons have combined committed Rs 1,500 crore towards coronavirus relief work. Chairman of Tata Trusts, Ratan Tata committed Rs 500 crore towards manufacturing of personal protective equipment, respiratory systems, testing kits and setting up modular treatment facilities and training of health workers. Following which, Tata Sons announced an additional Rs 1,000 crore support towards coronavirus fund. This is by far the biggest contribution by a business group in India. Out of the total fund, Rs 500 crore has been contributed towards PM-CARES fund.
Philanthropist Azim Premji's companies Wipro Ltd, Wipro Enterprises Ltd and Azim Premji Foundation, have together committed Rs 1,125 crore. Of the Rs 1,125 crore, Wipro Ltd's commitment is Rs 100 crore, Wipro Enterprises Ltd's is Rs 25 crore, and that of the Azim Premji Foundation is Rs 1,000 crore. These sums are in addition to the annual CSR activities of Wipro, and the usual philanthropic spends of the Azim Premji Foundation.
Mukesh Ambani-led Reliance Industries (RIL) has donated Rs 510 crore to the coronavirus relief work. This includes contribution of Rs 500 crore to the PM-CARES Fund and Rs. 5 crore each to the Chief Minister's Relief Fund of Maharashtra and Gujarat. RIL has also setup a 100-bed centre for COVID-19 patients at a hospital in Mumbai.
THE ATTRIBUTES BEHIND THE GLORY OF DELIVERY KING SWIGGY
INTRODUCTION
Swiggy is a food delivery application. It allows the users to access their application from Android, IOS, and website, to order food from nearby restaurants, delivering at an estimated time of 30 minutes at the doorstep. They partner with restaurants, have delivery services, and provide ratings that help the customer in picking eateries accordingly. At the time delivery of an order, a customer is entitled to give feedback, rate the food and the delivery services, which help the application, give the customer the best experience by gathering all data.
The company recently started with the tagline, ‘No order too small’, that is no minimum order for delivery, and faster delivery became the USP of the company. The company’s target audience is people who use smartphones regularly, 18-35 demographic. The tagline of Swiggy is, ‘Swiggy karo, phir jo chahe karo!’ which appears in the advertisements of Swiggy.
THE INCEPTION OF SWIGGY
In the year 2013, Sriharsha and Nandan came together to build a product that would connect courier companies across the country, called Bundl. Bundl was not such a huge success and these two co-founders wanted to focus on the food industry. They met Rahul who helped build the software. Hence, Swiggy was born in August 2014.
When Swiggy came to the market, the food delivery sector already had applications like Foodpanda, Tinyowl, and Ola Café. Foodpanda and Tinyowl were later acquired by Ola Cabs and Zomato respectively and Ola café later got closed. While all these companies were struggling, Swiggy already had around 100 restaurants on board, with around 70,000 orders monthly. They also received a cheque of $2 million from Accel and SAIF Partners in the year 2015. This is how the company began with a kick start.
Swiggy started in the year 2014, as a food delivery app. Eventually, Swiggy expanded in size and is working in 100 cities in India at present. In 2019, Swiggy also started its business in delivering packages to businesses and clients, with the application called, Swiggy Go.
THE INITIAL HI-CUPS FACED BY SWIGGY
Swiggy has both technical and non-technical issues that arise regularly. It is a challenge for Swiggy to calculate an estimate for each order made and making sure it gets delivered at the said time. The app also has a feature of rating for both the delivery services and the food served by restaurants; they gather this data and ensure to give the best experience to the customers.
THE BUSINESS AND REVENUE MODEL OF SWIGGY
The application works on the business model of hyper-local on-demand food delivery. Swiggy gets restaurants as partners that supply food to the customers. It has several delivery partners who aim at delivering food in less than 30 minutes. The revenue collected by Swiggy at the year ending March 2019 was Rs. 1, 128 crore.
THE LIFE SPAN OF DEADLY CORONAVIRUS ON DIFFERENT SURFACES
Coronavirus which has affected more than 5 lakh people and killed more than 24 thousand across the world till March 27 is spreading fast. The novel virus can spread through infected surfaces and can live between 3 to 72 hours hours on different surfaces such as plastic, metals, cardboard and even air.
As per a study published in New England Journal of Medicine, coronavirus (SARS-CoV-2) can be detected in air upto three hours. A person is more likely to catch the infection from air through an infected person rather than the surfaces that have the virus.
On copper, coronavirus can survive for upto 4 hours. As per the study, no traces of the virus could be seen or measured post the four-hour time-frame. Disinfecting the copper surface from time to time is a precautionary measure that can be used.
Coronavirus can live for a day on cardboard surfaces. As per the study, the virus (SARS-CoV-2) can survive for upto 24 hours on surfaces that are made out of cardboard. However the study also said that replicate data were noticeably "noisier" for cardboard than for other surfaces.
On objects and surfaces made of stainless steel, coronavirus can survive for upto 48 hours. The estimated median half-life of the virus was approximately 5.6 hours on stainless steel. The study published in New England Journal of Medicine notes that no visible virus (SARS-Cov-2) was measured after the 48-hour time period.
Coronavirus can live for upto 3 days on plastic surfaces. The SARS-COV-2 virus was more stable on plastic as compared to other surfaces such as metals and cardboard. The estimated median half-life of the virus was approximately 6.8 hours on plastic surfaces.
THE REPERCUSSIONS OF CORONAVIRUS' ON INDIA'S IMPORTS FROM CHINA
China's share in India's imports stand at 14 per cent. Since the outbreak of coronavirus trading between the two countries has been affected. India has a high dependency on China for manufacturing inputs. The industries that are impacted the most are:
APIs stand for active pharmaceutical ingredients. Indian companies imported 68 per cent of active pharmaceutical ingredients (API) from China in FY19. Indian pharma companies have said they have stock for 2-3 months, but the situation could worsen post May 2020.
India's electrical machinery and equipment has 40 per cent dependence on imports from China. However this number has reduced from 59.5 per cent in FY18 to 40 per cent in FY19. Although India has increased production of low-end electronic components. Import dependency on China is its major limitation.
Solar cells and modules which absorb sunlight to generate electricity are imported from China. As per a report from HDFC Bank, India's solar industry has 80 per cent dependence on Chinese manufacturers for solar products. As a result projects could be delayed in the next 4-6 months.
Consumer durables are the products that have a long use life such as air conditioners, refrigerators, and other household appliances. Around 45 per cent of consumer durables are imported from China. Currently an inventory for 2-3 months is being maintained by companies but the impact of the virus outbreak could be felt from Mar-Apr 20. Prices of these goods could rise in near future, according to the report.
Automobile sector, which accounts for 7.5 per cent of India's GDP and a massive 49 per cent of the manufacturing GDP, is already facing slowdown. The coronavirus lockdown has made the situation worse for the auto sector as 10 to 30 per cent of automotive components are supplied from China. If factories do not resume activity in China, it could adversely affect the sector.
Tourism sector comprises a broad chain of services such as tickets and booking, transportation, hotels, food and beverages. Since 2011, tourists from China visiting India were growing at 11% annually. China accounted for 3% of total foreign tourist arrivals in 2019.
HOW CEMENT INDUSTRY CAN BE THE BOOSTER ENGINE FOR INDIA?
1) The Indian cement industry is the second largest in the world in terms of production, but per capita consumption is still low at under 200kg compared to the world average of 500kg.
2) There has been consolidation in the industry with big players acquiring smaller regional cement companies. Cement companies operate by focusing on either quality or price.
3) Cement advertising now focuses more on emotional connections with consumers rather than just functional benefits due to information overload.
4) Government infrastructure projects and the housing sector are expected to drive demand growth, increasing per capita cement consumption to 435kg by 2030 and enabling an 82% expansion in production capacity.
ROBOTS AND HUMANS: COMBINED CAPABILITY WILL ENABLE BUSINESSES DELIVER UNEXPEC...
The last few years have seen a significant infusion of robots in various industries. This trend is expected to continue in the next 3-5 years. Almost 1 million robots are expected to be sold for enterprise use in 2020. There are primarily 3 types of robots - industrial, professional services and software robots.
Professional service robots (e.g., those used in healthcare, retail industries) and software robots (e.g., those used in functions such as Finance, HR, Procurement) will comprise a significant portion of these new robot sales. The market for professional services and software robots is growing much faster than that for industrial robots.
As the use of robots, increase in non-manufacturing industries, the companies which are able to combine the uniquely native human capabilities (e.g., inspiration, aspiration, emotion, empathy, imagination) with powerful robot capabilities (e.g., accurate transaction processing) will be able to re-imagine their business processes and deliver better and newer business outcomes for their stakeholders.
THE WAYS IN WHICH GEO -ENGINEERING COULD TRANSFORM THE ENVIRONMENT
Varun Kesavan discusses how geoengineering could be used to address the climate emergency. Specifically, solar radiation management techniques like stratospheric aerosol injection aim to reflect sunlight back into space to cool the planet. While once dismissed, major universities are now researching geoengineering due to the urgent threat of climate change. However, the large-scale effects are still uncertain and it may discourage climate action or have unintended impacts if halted. Overall, geoengineering shows potential to significantly benefit society and the environment according to studies, despite some risks, and could provide time to further address the root causes of climate change.
THE WAYS IN WHICH AUTOMATION REVOLUSIONS THE MANAGEMENT STRATEGY
Business strategy is being revolutionised by advances in automation technologies and management must follow. Management beliefs and practices must evolve with the new ways of production, distribution and consumption. Businesses are beginning to accept the inevitability of tech-enabled processes and tech-determined choices.
Industry 4.0 is about autonomy of machines. Advances in sensors, communication, computation, robotics, GPS etc have created possibilities of infusing machines with intelligence to automate both work and management. Machines are already collecting and sorting information, and management mostly involves dealing with people and making decisions. As Industry 4.0 evolves, a lot of decision-making will also be transferred to machines. But, it is not clear yet how machines will share ethical and legal responsibility for their actions.
THE SMES IN 2020: B2B PAYMENTS, DATA PRIVACY AMONG MAJOR PROBLEMS TO STAY IN ...
Several B2B payments and lending companies, over the last one year, emerged with solutions around banking, expense management, accounting/book-keeping, and Accounts Payable/Accounts Receivable (AP/AR) automation.
Slowly, but steadily, businesses are adopting software-as-a-service (SaaS) tools to manage their businesses better and move towards real digitisation away from manual and clunky processes to more elegant and friction-free processes.
Investors have taken notice of this opportunity in the B2B space and have stepped up their investments. A recent report by Venture Intelligence said that B2B fintech has secured $657 million in India so far this year, compared to $617 million by B2C fintech. Keeping this business payments transformation in mind, here are the top five topics that will be in the limelight in 2020:
THE TOP INNOVATIVE ECONOMIES IN THE WORLD
The World Economic Forum's Global Competitiveness Report for 2019 ranks 141 economies on their innovation capability. The innovation ecosystem is measured with the help of five sub-pillars-commercialization, Interaction, and diversity, administrative requirements, research and development, and entrepreneurial culture. Other important factors like education and the intensity of competitive skills they possess also help determine the country's innovation capabilities.
More from VARUN KESAVAN (20)
THE GROWTH ANALYSIS OF UNIFIED PAYMENTS INTERFACE (UPI) IN INDIA.docx
THE GROWTH ANALYSIS OF UNIFIED PAYMENTS INTERFACE (UPI) IN INDIA.docx
WILL ROBOTS REDUCE OR INCREASE HUMAN EMPLOYMENT OPPORTUNITIES?
WILL ROBOTS REDUCE OR INCREASE HUMAN EMPLOYMENT OPPORTUNITIES?
GLOBAL TOURISM SECTOR TO SUFFER $1.2 TRILLION DUE TO COVID-19 PANDEMIC
GLOBAL TOURISM SECTOR TO SUFFER $1.2 TRILLION DUE TO COVID-19 PANDEMIC
THE AFTERMATH EFFECTS OF CORONAVIRUS PANDEMIC ON THE INVESTMENTS IN REAL ESTA...
THE AFTERMATH EFFECTS OF CORONAVIRUS PANDEMIC ON THE INVESTMENTS IN REAL ESTA...
THE JOURNEY BEHIND THE GLORY OF LARGEST ONLINE NEWS PLATFORM DAILYHUNT
THE JOURNEY BEHIND THE GLORY OF LARGEST ONLINE NEWS PLATFORM DAILYHUNT
THE PATH BEHIND THE SHINING OF PAYMENTS APP MOBIKWIK
THE PATH BEHIND THE SHINING OF PAYMENTS APP MOBIKWIK
THE JOURNEY BEHIND THE GLORY OF ONLINE TRAVEL KING MAKEMY TRIP
THE JOURNEY BEHIND THE GLORY OF ONLINE TRAVEL KING MAKEMY TRIP
THE JOURNEY BEHIND THE SHINNING OF ONLINE INSURANCE AGGREGATOR POLICYBAZAAR
THE JOURNEY BEHIND THE SHINNING OF ONLINE INSURANCE AGGREGATOR POLICYBAZAAR
THE ROAD BEHIND THE GLORY OF GROCERY GIANT GROFERS
THE ROAD BEHIND THE GLORY OF GROCERY GIANT GROFERS
THE RELIANCE JIO WHICH TRANSFORMED THE FACE OF INDIAN TELECOM INDUSTRY
THE RELIANCE JIO WHICH TRANSFORMED THE FACE OF INDIAN TELECOM INDUSTRY
THE NOTABLE CONTRIBUTIONS MADE BY CORPORATE GIANTS DURING THE OUTBREAK OF THI...
THE NOTABLE CONTRIBUTIONS MADE BY CORPORATE GIANTS DURING THE OUTBREAK OF THI...
THE ATTRIBUTES BEHIND THE GLORY OF DELIVERY KING SWIGGY
THE ATTRIBUTES BEHIND THE GLORY OF DELIVERY KING SWIGGY
THE LIFE SPAN OF DEADLY CORONAVIRUS ON DIFFERENT SURFACES
THE LIFE SPAN OF DEADLY CORONAVIRUS ON DIFFERENT SURFACES
THE REPERCUSSIONS OF CORONAVIRUS' ON INDIA'S IMPORTS FROM CHINA
THE REPERCUSSIONS OF CORONAVIRUS' ON INDIA'S IMPORTS FROM CHINA
HOW CEMENT INDUSTRY CAN BE THE BOOSTER ENGINE FOR INDIA?
HOW CEMENT INDUSTRY CAN BE THE BOOSTER ENGINE FOR INDIA?
ROBOTS AND HUMANS: COMBINED CAPABILITY WILL ENABLE BUSINESSES DELIVER UNEXPEC...
ROBOTS AND HUMANS: COMBINED CAPABILITY WILL ENABLE BUSINESSES DELIVER UNEXPEC...
THE WAYS IN WHICH GEO -ENGINEERING COULD TRANSFORM THE ENVIRONMENT
THE WAYS IN WHICH GEO -ENGINEERING COULD TRANSFORM THE ENVIRONMENT
THE WAYS IN WHICH AUTOMATION REVOLUSIONS THE MANAGEMENT STRATEGY
THE WAYS IN WHICH AUTOMATION REVOLUSIONS THE MANAGEMENT STRATEGY
THE SMES IN 2020: B2B PAYMENTS, DATA PRIVACY AMONG MAJOR PROBLEMS TO STAY IN ...
THE SMES IN 2020: B2B PAYMENTS, DATA PRIVACY AMONG MAJOR PROBLEMS TO STAY IN ...
Recently uploaded
1Q24_HYUNDAI CAPITAL SERVICES INC. AND SUBSIDIARIES
1Q24_HYUNDAI CAPITAL SERVICES INC. AND SUBSIDIARIES
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
9356872877Sattamatka.satta.matka.satta matka.kalyan weekly chart.kalyan chart.kalyan jodi chart.kalyan penal chart.kalyan today.kalyan open.fix satta.fix fix fix Satta matka nambar.Pro Tips for Effortless Contract Management
Tired of chasing down expiring contracts and drowning in paperwork? Mastering contract management can significantly enhance your business efficiency and productivity. This guide unveils expert secrets to streamline your contract management process. Learn how to save time, minimize risk, and achieve effortless contract management.
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
AI Transformation Playbook: Thinking AI-First for Your Business
I dive into how businesses can stay competitive by integrating AI into their core processes. From identifying the right approach to building collaborative teams and recognizing common pitfalls, this guide has got you covered. AI transformation is a journey, and this playbook is here to help you navigate it successfully.
The Steadfast and Reliable Bull: Taurus Zodiac Sign
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
Efficient PHP Development Solutions for Dynamic Web Applications
Unlock the full potential of your web projects with our expert PHP development solutions. From robust backend systems to dynamic front-end interfaces, we deliver scalable, secure, and high-performance applications tailored to your needs. Trust our skilled team to transform your ideas into reality with custom PHP programming, ensuring seamless functionality and a superior user experience.
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【网址🎉ac55.net🎉】
【网址🎉ac55.net🎉】欧洲杯赌球是世界上历史最悠久的博彩公司之一。其历史可以追溯到十九世纪末，确切时间是1886年。这家英国公司拥有超过15000名员工，是博彩行业规模最大的公司。欧洲杯赌球是英国最受欢迎的实体博彩公司之一，其排名仅次于欧洲杯赌球，旗下2800家投注站遍布全英国。
The latest Heat Pump Manual from Newentide
𝐔𝐧𝐯𝐞𝐢𝐥 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐄𝐧𝐞𝐫𝐠𝐲 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐰𝐢𝐭𝐡 𝐍𝐄𝐖𝐍𝐓𝐈𝐃𝐄’𝐬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬
Explore the details in our newly released product manual, which showcases NEWNTIDE's advanced heat pump technologies. Delve into our energy-efficient and eco-friendly solutions tailored for diverse global markets.
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Transport Solution
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART KALYAN CHART
Enhancing Adoption of AI in Agri-food: Introduction
Introduction to the Panel on: Pathways and Challenges: AI-Driven Technology in Agri-Food, AI4Food, University of Guelph
“Enhancing Adoption of AI in Agri-food: a Path Forward”, 18 June 2024
Call 8867766396 Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian M...
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
DearbornMusic-KatherineJasperFullSailUni
My powerpoint presentation for my Music Retail and Distribution class at Full Sail University
Recently uploaded (20)
1Q24_HYUNDAI CAPITAL SERVICES INC. AND SUBSIDIARIES
1Q24_HYUNDAI CAPITAL SERVICES INC. AND SUBSIDIARIES
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
AI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your Business
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
Efficient PHP Development Solutions for Dynamic Web Applications
Efficient PHP Development Solutions for Dynamic Web Applications
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Enhancing Adoption of AI in Agri-food: Introduction
Enhancing Adoption of AI in Agri-food: Introduction
Call 8867766396 Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian M...
Call 8867766396 Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian M...
THE MAN BEHIND SUN PHARMA: DILIP SANGHVI
- 1. 1 THE MAN BEHIND SUN PHARMA: DILIP SANGHVI VARUN KESAVAN, RESEARCH SCHOLAR, E – MAIL ID – varunkesavan@yahoo.com Dilip Shanghvi (born 1 October 1955) is an Indian businessman and one of the country's richest people. He founded Sun Pharmaceuticals with a partner, Pradeep Ghosh.[3] The Government of India awarded him the civilian honour of the Padma Shri in 2016.[4] India Today magazine ranked him #8th in India's 50 Most powerful people of 2017 list.[
- 2. 2 EARLY LIFE AND EDUCATION Dilip was born in small town of Amreli in Gujarat to Shantilal Sanghvi and Kumud Sanghvi.[1][6] Shanghvi earned a Bachelor of Commerce degree from the University of Calcutta.[7] He is an alumnus of J. J. Ajmera High School and Bhawanipur Education Society College, from where he did his schooling and graduation, respectively.[8] He is married to Vibha Sanghvi.[6][9] The couple have a son, Aalok and daughter Vidhi from their marriage. Both of whom are currently working in Sun Pharmaceuticals. CAREER He started by helping his father in his wholesale generic drugs business in Kolkata.[1] It was during his work as a drugs distributor at Kolkata, he thought of manufacturing his own drugs instead of selling others' products.[1] Dilip Shanghvi started Sun Pharmaceutical Industries with capital of ₹10,000 in 1982 at Vapi, with one psychiatry drug and a partner, Pradeep Ghosh.[1][3] In 1997, Sun acquired Caraco Pharma, a loss- making American company, with the aim of expanding Sun's reach in the United States. Sun also acquired Israel's Taro Pharma in 2007.[11] Shanghvi stepped down as Chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor;[3] Shangvi became Managing Director.[12] In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2B in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and the fifth largest in the world, and made Daiichi the second largest shareholder in Sun.[13][14][15]
- 3. 3 As of August 2014, he had a net worth of $17.2 billion.